Lipid Metabolism Practice Questions

Q: Conversion of stearic acid to oleic acid is catalyzed by which enzyme?

D9 desaturase. **Explanation:** The conversion of **stearic acid** (a 18-carbon saturated fatty acid, 18:0) to **oleic acid** (a 18-carbon monounsaturated fatty acid, 18:1; Δ9) is a process of desaturation. **1. Why Option C is Correct:** In humans, the synthesis of monounsaturated fatty acids is catalyzed by the **Fatty Acid Desaturase system** (specifically **Δ9-desaturase**), located in the endoplasmic reticulum. This enzyme introduces a double bond between **carbons 9 and 10** of the fatty acid chain. Stearic acid is the primary substrate for this enzyme, resulting in the formation of oleic acid. This reaction requires molecular oxygen, NADH, and cytochrome b5. **2. Why Other Options are Incorrect:** * **Δ3 and Δ6 desaturases (Options A & B):** These enzymes are involved in the further desaturation of polyunsaturated fatty acids (PUFAs) like linoleic and α-linolenic acid to form longer-chain PUFAs (e.g., arachidonic acid). They do not act directly on saturated stearic acid to form oleic acid. * **Δ12 desaturase (Option D):** This enzyme introduces a double bond at the 12th position. **Humans lack Δ12 and Δ15 desaturases**, which is why linoleic (18:2; Δ9,12) and linolenic (18:3; Δ9,12,15) acids cannot be synthesized endogenously and are classified as **Essential Fatty Acids (EFA)**. **Clinical Pearls & High-Yield Facts:** * **Essential Fatty Acids:** Humans cannot introduce double bonds beyond the Δ9 position. Therefore, any fatty acid with a double bond at Δ12 or Δ15 must be obtained from the diet. * **Non-essentiality of Oleic Acid:** Since we possess Δ9-desaturase, oleic acid (Omega-9) is considered a non-essential fatty acid. * **Enzyme Components:** The desaturase system is a multienzyme complex consisting of **Desaturase, Cytochrome b5, and Cytochrome b5 reductase.**

Q: Delayed clotting in abetalipoproteinemia is due to:

Reduced clotting factor synthesis. **Explanation:** **Abetalipoproteinemia** is an autosomal recessive disorder caused by a mutation in the **Microsomal Triglyceride Transfer Protein (MTP)**. This defect prevents the assembly and secretion of ApoB-containing lipoproteins (Chylomicrons, VLDL, and LDL). **Why the correct answer is right:** The hallmark of abetalipoproteinemia is severe **fat malabsorption**. Because dietary fats cannot be packaged into chylomicrons, fat-soluble vitamins (A, D, E, and K) are not absorbed from the intestine. **Vitamin K** is a vital cofactor for the γ-carboxylation of clotting factors **II, VII, IX, and X**. A deficiency in Vitamin K leads to the production of non-functional clotting factors, resulting in a bleeding diathesis and delayed clotting. **Why incorrect options are wrong:** * **A & C (Decreased VLDL/Chylomicrons):** While these are characteristic biochemical findings in abetalipoproteinemia, they are the *cause* of malabsorption, not the direct mechanism for delayed clotting. Clotting is a protein-mediated process, not a lipid-mediated one. * **D (Decreased fatty acid synthesis):** De novo fatty acid synthesis occurs primarily in the liver and is not the primary defect in this condition. **Clinical Pearls for NEET-PG:** * **Blood Smear:** Look for **Acanthocytes** (spur cells) due to altered membrane lipid composition. * **Neurological symptoms:** Ataxia and retinitis pigmentosa occur due to severe **Vitamin E** deficiency. * **Biopsy:** Intestinal biopsy shows **lipid-laden enterocytes** (vacuoles) because triglycerides are trapped and cannot be exported. * **Labs:** Extremely low levels of Cholesterol and Triglycerides; absent ApoB-48 and ApoB-100.

Q: Which of the following is not synthesized from mevalonate?

Ubiquitin. **Explanation:** The synthesis of cholesterol involves the **Mevalonate pathway**, which produces several vital isoprenoid intermediates. The question asks which substance is *not* derived from this pathway. **Why Ubiquitin is the correct answer:** **Ubiquitin** is a small, highly conserved **regulatory protein** found in almost all eukaryotic tissues. Its primary function is to mark proteins for degradation via the proteasome (the Ubiquitin-Proteasome Pathway). It is synthesized through protein translation (amino acids), not the lipid-based mevalonate pathway. **Note:** Do not confuse **Ubiquitin** with **Ubiquinone** (Coenzyme Q). Ubiquinone *is* synthesized from mevalonate. **Why the other options are incorrect:** The mevalonate pathway follows this sequence: Mevalonate → Isopentenyl pyrophosphate (IPP) → **Geranyl pyrophosphate (GPP)** → **Farnesyl pyrophosphate (FPP)** → Squalene → Cholesterol. * **Geranyl pyrophosphate (Option B):** A 10-carbon intermediate in the pathway. * **Farnesyl pyrophosphate (Option A):** A 15-carbon intermediate used for cholesterol synthesis and the prenylation of proteins (like Ras). * **Dolichol (Option C):** A specialized lipid synthesized from farnesyl pyrophosphate. It is essential for the N-linked glycosylation of proteins in the endoplasmic reticulum. **High-Yield Clinical Pearls for NEET-PG:** * **HMG-CoA Reductase:** The rate-limiting enzyme of this pathway, inhibited by **Statins**. * **Statin-induced Myopathy:** May be caused by the depletion of **Ubiquinone (CoQ10)**, a side product of the mevalonate pathway required for the mitochondrial electron transport chain. * **Dolichol deficiency:** Leads to Congenital Disorders of Glycosylation (CDG). * **Protein Prenylation:** FPP and GPP are used to anchor proteins (e.g., Ras G-protein) to cell membranes.

Q: Arachidonic acid is synthesized from which of the following?

Linoleic acid. **Explanation:** Arachidonic acid is a **20-carbon polyunsaturated fatty acid (PUFA)** with four double bonds (C20:4, ω-6). In the human body, it is synthesized from **Linoleic acid** (C18:2, ω-6). **1. Why Linoleic acid is correct:** Linoleic acid is an **essential fatty acid** because humans lack the enzymes (desaturases) to introduce double bonds beyond carbon 9. However, once linoleic acid is consumed, the body can convert it into arachidonic acid through a three-step pathway: * **Desaturation:** Addition of a double bond by $\Delta^6$-desaturase. * **Elongation:** Addition of two carbons. * **Desaturation:** Addition of another double bond by $\Delta^5$-desaturase. Since both belong to the **omega-6 (ω-6) family**, linoleic acid serves as the direct precursor. **2. Why other options are incorrect:** * **Stearic acid (C18:0):** A saturated fatty acid. While it can be desaturated to oleic acid, it cannot be converted into essential ω-3 or ω-6 PUFAs. * **Linolenic acid (C18:3, ω-3):** This is the precursor for **EPA** (Eicosapentaenoic acid) and **DHA** (Docosahexaenoic acid). It belongs to the ω-3 family and cannot be converted into ω-6 arachidonic acid. * **Oleic acid (C18:1, ω-9):** A monounsaturated fatty acid synthesized by the body. It cannot be converted into polyunsaturated essential fatty acids. **Clinical Pearls for NEET-PG:** * **Prostaglandin Synthesis:** Arachidonic acid is the primary substrate for the synthesis of eicosanoids (prostaglandins, thromboxanes, and leukotrienes) via the COX and LOX pathways. * **Essentiality:** Arachidonic acid becomes "conditionally essential" only if linoleic acid is deficient in the diet. * **Rate-limiting step:** The $\Delta^6$-desaturase reaction is the rate-limiting step in the conversion of linoleic to arachidonic acid.

Q: Steroid synthesis takes place at?

Smooth endoplasmic reticulum. **Explanation:** The **Smooth Endoplasmic Reticulum (SER)** is the primary site for the synthesis of lipids, phospholipids, and **steroids**. Steroidogenesis involves the conversion of cholesterol into various hormones (like cortisol, testosterone, and estrogen). The SER contains the essential enzymes, such as the cytochrome P450 superfamily, required for these biosynthetic pathways. Consequently, cells that specialize in steroid production—such as those in the adrenal cortex, testes (Leydig cells), and ovaries—possess an extensively developed SER. **Analysis of Incorrect Options:** * **A. Ribosomes:** These are the sites of **protein synthesis** (translation). They do not contain the enzymatic machinery for lipid or steroid metabolism. * **C. Peroxisomes:** These organelles are involved in **beta-oxidation of very-long-chain fatty acids (VLCFA)**, hydrogen peroxide metabolism, and bile acid synthesis, but they are not the primary site for steroid hormone assembly. * **D. Lysosomes:** Known as the "suicidal bags" of the cell, these contain hydrolytic enzymes for the **degradation** of macromolecules and autophagy, rather than synthesis. **High-Yield Facts for NEET-PG:** * **Mitochondria Connection:** While the SER is the main site, the initial and rate-limiting step of steroidogenesis (conversion of cholesterol to pregnenolone) actually occurs in the **mitochondria**. Therefore, steroid-producing cells are characterized by abundant SER *and* mitochondria with tubular cristae. * **Rough ER (RER):** In contrast to SER, the RER is studded with ribosomes and is the site for synthesizing proteins destined for secretion or membrane insertion (e.g., insulin). * **Sarcoplasmic Reticulum:** A specialized form of SER in muscle cells that stores and releases **Calcium ($Ca^{2+}$)**, essential for contraction.

Q: Which of the following oils contains a high quantity of saturated fatty acids?

Coconut oil. **Explanation:** The core concept tested here is the classification of dietary fats based on their degree of saturation. Fatty acids are categorized into **Saturated Fatty Acids (SFA)**, which have no double bonds, and **Unsaturated Fatty Acids (UFA)**, which contain one or more double bonds. **Why Coconut Oil is Correct:** While most plant-derived oils are rich in unsaturated fats, **Coconut oil** is a notable exception. It contains approximately **90-92% saturated fatty acids**, primarily in the form of Medium-Chain Triglycerides (MCTs) like Lauric acid (C12), Myristic acid (C14), and Palmitic acid (C16). Because it lacks double bonds, it remains solid at room temperature and is highly resistant to oxidation. **Why the Other Options are Incorrect:** * **Sunflower oil, Safflower oil, and Soybean oil** are all categorized as **Polyunsaturated Fatty Acids (PUFAs)**. * **Safflower oil** is particularly high in Linoleic acid (Omega-6), making it one of the most unsaturated vegetable oils. * **Soybean oil** contains a mix of Linoleic acid and Alpha-linolenic acid (Omega-3). * **Sunflower oil** is a rich source of Vitamin E and Linoleic acid. **High-Yield NEET-PG Pearls:** 1. **MCT Advantage:** The MCTs in coconut oil are absorbed directly into the portal circulation without requiring chylomicron formation or pancreatic lipase, making them a preferred energy source in malabsorption syndromes. 2. **P/S Ratio:** The Polyunsaturated to Saturated fat ratio is an indicator of the "healthiness" of an oil. A higher ratio is generally considered cardioprotective. 3. **Essential Fatty Acids:** Remember that Linoleic (ω-6) and Alpha-linolenic (ω-3) acids are "essential" because the human body lacks the enzymes (desaturases) to introduce double bonds beyond carbon 9. 4. **Palm Oil:** Like coconut oil, palm oil is another plant source high in saturated fats (Palmitic acid).

Q: Which of the following compounds directly inhibits the expression of the HMG-CoA reductase gene?

Cholesterol. **Explanation:** The correct answer is **Cholesterol (Option D)**. **Mechanism of Action:** HMG-CoA reductase is the rate-limiting enzyme in cholesterol biosynthesis. Its regulation occurs at multiple levels, most notably through **transcriptional control**. When intracellular cholesterol levels are high, cholesterol (and its derivatives like oxysterols) inhibits the expression of the HMG-CoA reductase gene. This process involves **SREBP (Sterol Regulatory Element-Binding Protein)** and **SCAP (SREBP Cleavage-Activating Protein)**. When cholesterol is abundant, it binds to SCAP, keeping the SREBP-SCAP complex anchored in the endoplasmic reticulum. This prevents SREBP from moving to the nucleus to act as a transcription factor, thereby decreasing the synthesis of HMG-CoA reductase mRNA. **Analysis of Incorrect Options:** * **A. Superoxide Dismutase:** This is an antioxidant enzyme that neutralizes free radicals; it has no role in the cholesterol biosynthetic pathway. * **B. HMG-CoA:** This is the substrate for the enzyme, not a transcriptional inhibitor. * **C. Isopentenyl pyrophosphate:** This is an intermediate in the mevalonate pathway. While it is a precursor to cholesterol, it does not directly regulate gene expression of the reductase. **High-Yield Clinical Pearls for NEET-PG:** * **Statins:** These are competitive inhibitors of HMG-CoA reductase. * **Hormonal Regulation:** HMG-CoA reductase is **activated by Insulin** (via dephosphorylation) and **inhibited by Glucagon/Epinephrine** (via phosphorylation by AMPK). * **Degradation:** High cholesterol also promotes the rapid proteolysis (ubiquitination) of the HMG-CoA reductase enzyme itself. * **Location:** The enzyme is located in the **Endoplasmic Reticulum (ER)** membrane.

Q: 11-hydroxylase deficiency leads to which of the following?

Hypertension. **Explanation:** Congenital Adrenal Hyperplasia (CAH) due to **11β-hydroxylase deficiency** is the second most common cause of CAH. Understanding the steroid biosynthesis pathway is key to solving this [1]: 1. **Why Hypertension is Correct:** 11β-hydroxylase is responsible for converting **11-deoxycorticosterone (DOC)** to corticosterone and **11-deoxycortisol** to cortisol. When this enzyme is deficient, there is a buildup of 11-deoxycorticosterone (DOC) [1]. DOC is a potent mineralocorticoid [2]. Its accumulation leads to sodium and water retention and potassium excretion, resulting in **hypertension** and hypokalemia. This distinguishes it from 21-hydroxylase deficiency, which presents with hypotension (salt-wasting). 2. **Why other options are incorrect:** * **Hypotension:** This occurs in 21-hydroxylase deficiency due to the lack of mineralocorticoids (aldosterone). In 11β-hydroxylase deficiency, the excess DOC prevents hypotension. * **Hypoglycemia:** While cortisol (a glucocorticoid) is low, the clinical hallmark of 11β-hydroxylase deficiency is the mineralocorticoid excess effect (hypertension) and androgen excess. * **Normal Puberty:** This is incorrect because the "shunting" of precursors leads to **excess adrenal androgens**. This causes virilization in females (ambiguous genitalia) and precocious pseudopoterty in males. **High-Yield Clinical Pearls for NEET-PG:** * **The "Rule of 1s":** If the enzyme starts with **1** (11β-hydroxylase, 17α-hydroxylase), it causes **Hypertension**. * **Virilization:** Both 21 and 11β-hydroxylase deficiencies cause virilization (increased androgens), whereas 17α-hydroxylase deficiency causes delayed puberty/sexual infantilism. * **Biochemical Marker:** Elevated levels of **11-deoxycortisol** and **S-androstenedione** are diagnostic for 11β-hydroxylase deficiency.

Q: A 15-year-old male presents with abdominal pain. General examination reveals xanthomas in clusters on his back, buttocks, arms, and legs. Percussion indicates hepatomegaly and splenomegaly. What is the most probable diagnosis for this child?

Type I Hyperlipoproteinemia. ### Explanation **Correct Option: A. Type I Hyperlipoproteinemia** The clinical triad of **eruptive xanthomas** (clusters on the back and buttocks), **hepatosplenomegaly**, and **abdominal pain** (due to acute pancreatitis) in a young patient is classic for Type I Hyperlipoproteinemia (Familial Chylomicronemia Syndrome). * **Mechanism:** It is caused by a deficiency in **Lipoprotein Lipase (LPL)** or its cofactor **Apo C-II**. * **Pathophysiology:** This leads to an inability to clear chylomicrons from the blood, resulting in massive hypertriglyceridemia. The milky appearance of plasma and "creamy layer" on standing are characteristic laboratory findings. **Incorrect Options:** * **B & C (Hypercholesterolemia):** These typically present with elevated LDL and cholesterol. Clinical signs include **tendon xanthomas** (Achilles) and xanthelasma, rather than eruptive xanthomas and hepatosplenomegaly. They are associated with premature atherosclerosis, not acute pancreatitis. * **D (Abetalipoproteinemia):** This is a deficiency of Microsomal Triglyceride Transfer Protein (MTP), leading to an absence of Apo B-48 and B-100. Patients present with malabsorption, fat-soluble vitamin deficiency, and **acanthocytosis** (spur cells), with very *low* lipid levels. **High-Yield Clinical Pearls for NEET-PG:** * **Type I:** High Chylomicrons; Deficiency of LPL/Apo C-II; Risk of Pancreatitis (No increased risk of atherosclerosis). * **Type IIa:** High LDL; Deficiency of LDL receptors; Risk of early MI and Tendon Xanthomas. * **Type III (Dysbetalipoproteinemia):** Deficiency of **Apo E**; characterized by **Palmar Xanthomas**. * **Type IV:** High VLDL; associated with obesity and insulin resistance.

Question 1

Conversion of stearic acid to oleic acid is catalyzed by which enzyme?

Accepted Answer

D9 desaturase

Answer

D3 desaturase

Answer

D6 desaturase

Answer

D12 desaturase

Question 2

Delayed clotting in abetalipoproteinemia is due to:

Accepted Answer

Reduced clotting factor synthesis

Answer

A decreased VLDL

Answer

Decreased chylomicrons

Answer

Decreased fatty acid synthesis

Question 3

Which of the following is not synthesized from mevalonate?

Accepted Answer

Ubiquitin

Answer

Farnesyl pyrophosphate

Answer

Geranyl pyrophosphate

Answer

Dolichol

Question 4

Arachidonic acid is synthesized from which of the following?

Accepted Answer

Linoleic acid

Answer

Stearic acid

Answer

Linolenic acid

Answer

Oleic acid

Question 5

Steroid synthesis takes place at?

Accepted Answer

Smooth endoplasmic reticulum

Answer

Ribosomes

Answer

Peroxisomes

Answer

Lysosomes

Question 6

Which of the following oils contains a high quantity of saturated fatty acids?

Accepted Answer

Coconut oil

Answer

Sunflower oil

Answer

Safflower oil

Answer

Soybean oil

Question 7

Which of the following compounds directly inhibits the expression of the HMG-CoA reductase gene?

Accepted Answer

Cholesterol

Answer

Superoxide Dismutase

Answer

HMG-CoA

Answer

Isopentenyl pyrophosphate

Question 8

Which of the following apolipoproteins is synthesized in the liver as part of the coat of very low-density lipoproteins (VLDLs)?

Accepted Answer

ApoB-100

Answer

ApoA-I

Answer

ApoB-48

Answer

ApoC-II

Question 9

11-hydroxylase deficiency leads to which of the following?

Accepted Answer

Hypertension

Answer

Hypotension

Answer

Hypoglycemia

Answer

Normal puberty

Question 10

A 15-year-old male presents with abdominal pain. General examination reveals xanthomas in clusters on his back, buttocks, arms, and legs. Percussion indicates hepatomegaly and splenomegaly. What is the most probable diagnosis for this child?

Accepted Answer

Type I Hyperlipoproteinemia

Answer

Autosomal Dominant Hypercholesterolemia Type I

Answer

Autosomal Recessive Hypercholesterolemia

Answer

Abetalipoproteinemia

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?